These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2474095)

  • 1. The sympathetic nervous system and converting enzyme inhibition.
    Ball SG
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S17-21. PubMed ID: 2474095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetic nervous system during converting enzyme inhibition.
    Crozier IG; Teoh R; Kay R; Nicholls MG
    Am J Med; 1989 Dec; 87(6B):29S-32S. PubMed ID: 2574949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between the renin-angiotensin-aldosterone and sympathetic nervous systems.
    Saxena PR
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S80-8. PubMed ID: 1382170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function.
    DiBona GF
    Hypertension; 2000 Dec; 36(6):1083-8. PubMed ID: 11116129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of sympathetic control by ACE inhibitors.
    Dominiak P
    Eur Heart J; 1993 Nov; 14 Suppl I():169-72. PubMed ID: 8293770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiated response of the sympathetic nervous system to angiotensin-converting enzyme inhibition in hypertension.
    Johansson M; Elam M; Rundqvist B; Eisenhofer G; Herlitz H; Jensen G; Friberg P
    Hypertension; 2000 Oct; 36(4):543-8. PubMed ID: 11040233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic converting enzyme inhibition reduces the vasomotor response to reflex sympathetic activation in man.
    Morganti A; Grassi G; Sala C; Capozi A; Turolo L; Sabadini E; Bolla G; Mancia G; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S259-62. PubMed ID: 2856713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
    Bernasconi M; Marone C; Beretta-Piccoli C; Lepori G; Shaw S; Weidmann P
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):348-55. PubMed ID: 1829371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.
    Ligtenberg G; Blankestijn PJ; Oey PL; Klein IH; Dijkhorst-Oei LT; Boomsma F; Wieneke GH; van Huffelen AC; Koomans HA
    N Engl J Med; 1999 Apr; 340(17):1321-8. PubMed ID: 10219067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
    Weir MR; Dzau VJ
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure.
    Francis GS
    Am Heart J; 1989 Sep; 118(3):642-8. PubMed ID: 2570521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition.
    Brunner HR; Waeber B; Nussberger J
    J Hypertens Suppl; 1988 Dec; 6(3):S1-5. PubMed ID: 3066876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sympathetic nervous system and the renin-angiotensin-aldosterone system in cardiovascular disease.
    Cody RJ
    Am J Cardiol; 1997 Nov; 80(9B):9J-14J. PubMed ID: 9375943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition.
    Weber MA; Neutel JM; Smith DH
    Am Heart J; 1992 May; 123(5):1414-20. PubMed ID: 1575168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment.
    Neumann J; Ligtenberg G; Klein IH; Boer P; Oey PL; Koomans HA; Blankestijn PJ
    Hypertension; 2007 Mar; 49(3):506-10. PubMed ID: 17224471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.
    Adams KF
    Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S4-13. PubMed ID: 15160833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects.
    Lang CC; Stein CM; He HB; Wood AJ
    Clin Pharmacol Ther; 1996 Jun; 59(6):668-74. PubMed ID: 8681492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure.
    Grassi G; Cattaneo BM; Seravalle G; Lanfranchi A; Pozzi M; Morganti A; Carugo S; Mancia G
    Circulation; 1997 Aug; 96(4):1173-9. PubMed ID: 9286946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-adrenergic effects of angiotensin converting enzyme inhibitors.
    Bristow MR; Abraham WT
    Eur Heart J; 1995 Nov; 16 Suppl K():37-41. PubMed ID: 8869134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.